PROF250117P12500
- 0.00
- 0.000.00%
Profound Medical Newsroom
Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break
Chairman of the Board & CEO of Profound Medical Picks Up 3.7% More Stock
Express News | Profound Medical Corp : Raymond James Cuts Target Price to $17 From $19
Raymond James Initiates Profound Medical(PROF.US) With Buy Rating, Announces Target Price $17
Profound Medical Price Target Lowered to $17 From $19 at Raymond James
Profound Medical | 6-K: Report of foreign private issuer (related to financial reporting)
Profound Stock Slides 6% on $35M Public Offering Pricing
Profound Medical Prices US$35 Million Underwritten Public Offering of Common Shares
Profound Medical Trading Halted, News Pending
Express News | Trading Halt: Halted at 9:10:08 A.m. ET - Trading Halt: Halt News Pending
Profound Medical Down 6.7% In US After Hours As Announces Proposed Public Offering of Common Shares
Profound Medical Announces Common Share Offering, No Amount Given
Profound Medical Brief: Announcing Proposed Public Offering of Common Shares
Profound Medical, Siemens Healthineers Enter Co-sales, Co-marketing Agreement
Lake Street Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $17
Lake Street Sticks to Its Buy Rating for Profound Medical (PRN)
Profound Medical Brief: Says It and Siemens Healthineers to Offer a "Complete Solution" for MRI-guided Prostate Therapy
Profound Medical Advancements in Prostate Treatment
Profound Medical Brief: Says to Unveil Next TULSA-AI Module, 'UA Alignment Assistant'
Profound Medical to Unveil Next TULSA-AI Module, 'UA Alignment Assistant'